UCSF

Topics and Expertise: drug delivery

Prien and MacWilliam bequests establish new endowed professorships

The UCSF School of Pharmacy has established new endowed faculty positions to be held by the chairs of two School departments.

MacDougall study finds severe sepsis alert speeds drug delivery

Sepsis occurs when the body responds to an infection with a mix of tissue-damaging inflammation and anti-inflammatory responses. This biological storm can lead to acute organ dysfunction (severe sepsis) and dropping blood pressure that does not respond to intravenous fluids (septic shock).

Desai Lab develops nanodevices to aid artery repair

Research in the laboratory of Tejal Desai, PhD, is creating new kinds of drug delivery devices to reduce the scarring and inflammation that can undermine stents—metal mesh tubes implanted to prop open blocked arteries, including in the heart.

Tejal Desai, PhD

Professor

I am a bioengineer focusing on micro and nanofabrication techniques to create new devices for drug and cell delivery as well as biomaterials for cell and tissue regeneration. I am the immediate past chair (7 years) of the Department of Bioengineering and Therapeutic Sciences, a joint department in...

Leslie Benet, PhD

Professor

New NIH funding awarded to the Department of Pharmaceutical Chemistry in 2011

New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included these on-going projects by faculty in the Department of Pharmaceutical Chemistry:

Fischbach and Desai focus on “micro” solutions to improve health with drugs

Faculty members in the Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine, share their research on the human microbiome and microfabricated drug delivery systems and their hopes for how their science will improve the health of patients.

Desai’s drug delivery research focus of agreement between UCSF and Zcube

Drug delivery research led by UCSF’s Tejal Desai, PhD, will now be supported by an exclusive worldwide license agreement between UCSF and Zcube

Reflection: 30 years of top NIH funding for UCSF School of Pharmacy

Table of contents

Introduction
Budget significance
Reasons for past success
A decade of funding for bioinformatics
New drug discovery directions attract support

Scientists explain how they are making therapeutics “intelligent”

UCSF scientists describe how their research is aiming to make therapeutics sophisticated, highly effective, and tailored to the different needs of individuals.

Pages